Version en castellano
PEOPLE
 
  Pedro Reche
  Magdalena Molero Abraham
 
 People   of Imunomedicine Group
 

Pedro Reche, Group Leader
Pedro is Chemist (1990) with a Ph.D. in Molecular Biology/Biochemistry (1995) from the University of Granada, Spain. He obtained post-doctoral training at the Department of Biochemistry of the University of Cambridge (England) (1995-1998) and the DNAX Research Institute, California, USA (1998-2001). From 2001 to 2006, he worked at the Dana-Farber Cancer Institute, Boston, Ma, USA, directing the Bioinformatics cores of the Molecular Immunology Foundation and the Cancer Vaccine Center, holding also the appointment of Instructor of Harvard Medical School. Late 2006, he joined the University Complutense to establish the Immunomedicine Group.

Pedro is a multidisplinary scientist with relevant contributions on the fields of Biochemistry, Molecular Biology, Bioinformatics and Immunology. He has published over 60 articles in peer review journals that have received over 5500 citations (h-index = 31).

Marta Gomez Perosanz, PhD Student
Marta has a bachelors's Degree in Biology (2015) and a master Degree in Biomedical Investigation (2016) both from Universidad Complutense of Madrid. She has two years of experience in the Department of Clinical Microbiology and Infectious Diseases of the Hospital General Universitario Gregorio MaraƱon of Madrid. After completing her master degree Marta joined the Immumedicine Group at the School of Medicine of the Complutense University where she is pursuing her PhD, which is based on computer-assisted design of epitope-based vaccines. Marta is supported by a Harvard-Complutense Fellowship

Jose Luis Sanchez-Trincado , PhD Student
Jose Luis has a Bachelor's Degree in Biotechnology (2015), from the Pablo de Olavide University, followed by a Master'sDegree in Advanced Genetics, from the Autonomous University of Barcelona (2016). Then, he worked as research assistant in Severo Ochoa's Center for Molecular Biology to work on Huntington's disease. Jose Luis joined the Immunomedine group early in 2017 to complete his PhD in T-cell immunology. Jose Luis is supported by a Harvard-Complutense Fellowship


Contact Us    |   Immunomedicine Group    |